According to Regeneron Pharmaceuticals's latest financial reports the company has HK$70.05 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | HK$69.96 B | -17.39% |
2023-12-31 | HK$84.69 B | 40.01% |
2022-12-31 | HK$60.49 B | 36.23% |
2021-12-31 | HK$44.40 B | 59.69% |
2020-12-31 | HK$27.80 B | 11.08% |
2019-12-31 | HK$25.03 B | 13.77% |
2018-12-31 | HK$22.00 B | 99.81% |
2017-12-31 | HK$11.01 B | 36.72% |
2016-12-31 | HK$8.05 B | -0.58% |
2015-12-31 | HK$8.10 B | 15.99% |
2014-12-31 | HK$6.98 B | 29.79% |
2013-12-31 | HK$5.38 B | 125.34% |
2012-12-31 | HK$2.38 B | -41.65% |
2011-12-31 | HK$4.09 B | 110.9% |
2010-12-31 | HK$1.94 B | -26.67% |
2009-12-31 | HK$2.64 B | -27.86% |
2008-12-31 | HK$3.66 B | -38.61% |
2007-12-31 | HK$5.97 B | 67.3% |
2006-12-31 | HK$3.57 B | 54.32% |
2005-12-31 | HK$2.31 B | 0.63% |
2004-12-31 | HK$2.30 B | 1.01% |
2003-12-31 | HK$2.27 B | 10.49% |
2002-12-31 | HK$2.06 B | -31.36% |
2001-12-31 | HK$3.00 B | 227.34% |
2000-12-31 | HK$0.91 B | 78.36% |
1999-12-31 | HK$0.51 B | 235.26% |
1998-12-31 | HK$0.15 B | -31.5% |
1997-12-31 | HK$0.22 B | -16.07% |
1996-12-31 | HK$0.26 B |